House Passes US OTC Monograph Reform And Committee Clears HSA Change
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
Next step for OTC monograph reform legislation is Senate consideration; market exclusivity periods are likely focus of House/Senate conference. Separate bill to allow consumers to use health savings accounts to buy OTC drugs without a doctor's prescription clears House Ways and Means panel.
You may also be interested in...
OTC Monograph Legislation Clears Another Hurdle Despite Exclusivity Concerns
Democrats' opposition to the length of the exclusivity allowed for some new monograph products didn't stop them from voting to send US OTC monograph overhaul legislation on for a vote by the full House. House/Senate differences and some members' questions on whether new exclusivity is needed could make it harder for reforms to pass this year.
Direct OTC Purchases With Pre-Tax Accounts Swing On ACA Change, Not Repeal
Sens. Pat Roberts, R-KS, and Heidi Heitkamp, D-ND, and Reps. Lynn Jenkins, R-KS and Ron Kind, D-WI, once again introduce the Restoring Access to Medications Act, proposing amending rather than repealing ACA.
Direct OTC Purchases With Pre-Tax Savings Accounts Passes House
The Restoring Access to Medication Act, HR 1270, sponsored by Reps. Lynn Jenkins, R-KS, and Ron Kind, D-WI, passes the House in a 243-164 vote.